Global 
Germany 
Spain 
France Glooko Insights
Stay up-to-date on our latest news and insights, enhancements to our connected care platform, and Team Glooko happenings.
2025 Global Diabetes Report: Transforming Diabetes Management Through Actionable Insights
June 20, 2025The Glooko 2025 Global Diabetes Report offers a comprehensive look at how real-world data can drive better outcomes in diabetes care. Powered by billions of data points across 30+ countries, this report uncovers meaningful trends in glycemic management, technology adoption, and behaviors among people living with Type 1, Type 2, and gestational diabetes. From the rise of remote monitoring to the impact of advanced technologies like Continuous Glucose Monitors (CGMs) and Automated Insulin Delivery (AID) systems, this report explores how personalized insights can be used to better inform personalized care, predict risk, and guide clinical decision-making. Whether you’re a clinician, researcher, or innovator in diabetes management technology, this report highlights how data can be turned into action — helping to shape a smarter, more connected future of diabetes management. Download the report.
Learn more
Transforming Diabetes Management: A Step Forward with Abbott’s FreeStyle Libre CGMs and Glooko
June 18, 2025At Glooko, we are committed to simplifying diabetes insights and management for people living with diabetes and healthcare providers alike. That’s why our platform is compatible with more than 200 diabetes and health monitoring devices and growing. As a company, we could not be more pleased to share that we recently expanded our capabilities to integrate with Abbott’s FreeStyle Libre CGMs in the United States. This integration brings glucose data to more clinics and health systems in our all-in-one solutions for diabetes management. This milestone is more than just a technological advancement — it’s about empowering people with Type 1, Type 2, and gestational diabetes, as well as prediabetes, to become active owners in their health. By combining the precision of Abbott’s FreeStyle Libre CGMs with Glooko’s comprehensive platform, we can provide people living with diabetes and their care teams, including endocrinologists and nurses, with a unified, holistic view of diabetes management and irrefutable information. TFrom glucose trends to lifestyle behaviors like diet and physical activity, this latest integration ensures that critical insights are easily accessible when and where they are needed most. For healthcare providers and health systems, this means the ability to seamlessly access and analyze patients’ CGM data through Glooko and established electronic health record (EHR) solutions, more informed decision-making, and improved patient outcomes. For people living with diabetes, it means greater confidence in their care and health. As the number of people with diabetes continues to grow, the need for seamless, data-driven solutions has never been greater. Our new integration with Abbott’s FreeStyle Libre CGMs represents a significant step forward in delivering better, more connected care. This partnership is sure to have a positive impact on the millions of people who rely on FreeStyle Libre CGMs and Glooko.
Learn more
Transforming Diabetes Care in the United Kingdom: Shaping the Future through Technology, Data, and Partnerships
June 9, 2025In the United Kingdom, diabetes technology has rapidly advanced over the past two decades, with platforms like Glooko playing a central role in simplifying care and management. In honor of Diabetes Week U.K. (9 June to 15), we’re taking a look at the state of diabetes, technology designed to better manage the condition, and the outlook on the evolution of diabetes care and technology. The State of Diabetes in the United Kingdom Diabetes is a significant public health concern in the U.K. According to Diabetes U.K., more than 5.8 million people are currently living with the condition. Of these, approximately 4.6 million have been diagnosed and an estimated 1.3 million people may be living with undiagnosed Type 2 diabetes. Of those diagnosed with diabetes in the U.K., Type 2 diabetes accounts for approximately 90% of cases. While risk factors for Type 1 diabetes include family history and the presence of other autoimmune conditions, Type 2 diabetes risk is heightened obesity, family history, a history of gestational diabetes, specific medications, and other factors. To address the growing prevalence of diabetes and support those affected, the National Health Service (NHS) offers various education programs aimed at empowering individuals with the knowledge and skills necessary to manage their diabetes effectively, improve health outcomes, and reduce the risk of complications. For individuals with Type 2 diabetes, programs like DESMOND (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) and the X-PERT Diabetes Programme provide education on managing the condition through lifestyle changes and self-monitoring. For those with Type 1 diabetes, the DAFNE (Dose Adjustment For Normal Eating) program offers guidance on insulin management and dietary considerations and Digibete helps young people, families, and communities better manage Type 1 diabetes. Additionally, the VICTOR program is designed for adults with Type 2 diabetes who are on insulin therapy and focuses on adjusting insulin doses in response to routine changes. Diabetes Technology Today In the U.K., diabetes technology is advancing quickly with Glooko helping streamline data management across compatible diabetes and health monitoring devices, including: Hybrid closed loop (HCL) systems, which combine continuous glucose monitoring (CGM) with insulin pumps to automatically adjust insulin delivery based on real-time data. Devices like Tandem t:slim X2 require cable downloads, while mylife Loop powered by CamAPS® FX and Omnipod® 5 use cloud-to-cloud integration. CGMs provide glucose trends and alerts and are often compatible with pumps and cloud platforms. Abbott FreeStyle Libre CGMs data can be seen within Glooko through the upload of data from HCL-compatible insulin pumps. Fitness and health monitoring apps can track steps, weight, and blood pressure. Smart pens and connected pens allow for remote or in-clinic dose tracking. Transforming Diabetes Care in the United Kingdom with Glooko Across the country, more than 85,000 people living with diabetes use Glooko’s digital health platform to manage their diabetes and more than 500 clinics are using Glooko to provide better care to their patients.* Through our data*, we identified key metrics for time in range for people with Type 1, Type 2, and gestational diabetes in the U.K. using Glooko during 2024. Type Time In Range (TIR) | 3.9-10 mmol/l Time in Tight Range (TITR) | 3.9-7.8 mmol/l Type 1 Diabetes 64% 41% Type 2 Diabetes 58% 34% Gestational Diabetes 74% 50% Today, there is an increased interest in TITR and TIR as a result of the recent technology available for managing diabetes. The Glooko diabetes data management platform helps healthcare providers monitor TIR and TITR to improve glycemic outcomes for people living with diabetes, bringing data from multiple devices into one platform with comprehensive charts and graphs. It ensures consistent data access — even without connected devices — and meets high standards for data protection, including GDPR compliance, to support safe, effective, and standardised diabetes care. The Future of Diabetes Care in the United Kingdom The future of diabetes care in the U.K. lies in advancing technology and deeper collaboration. Recent key developments include moving towards fully closed loop systems, integrating AI-enabled personalized insights, and aligning diabetes management with weight loss medications. Continued innovation will help provide more tailored, effective treatment options for people living with diabetes. Progress also depends on strong partnerships with leading diabetes organisations like the Diabetes Technology Network (DTN-UK) and Diabetes National Networking Forums (NNF). The future of diabetes care in the U.K. lies in advancing technology and deeper collaboration. Recent key developments include moving towards fully closed loop systems, integrating AI-enabled personalized insights, and aligning diabetes management with weight loss medications. Continued innovation will help provide more tailored, effective treatment options for people living with diabetes. By showcasing technologies such as hybrid closed loop systems at local events from these leading organisations and through initiatives like our Academy program, a collaboration between Glooko and the Association of British Clinical Diabetologists(ABCD)/DTN-UK providing free education for medical professionals in the U.K., we help educate, support, and empower both clinicians and people living with diabetes across the country. *Internal Glooko data; based on active Glooko users that synced during 2024
Learn more
New Glooko Web 25.1 and Mobile 6.11 Release Enhances Reporting and Security
June 5, 2025As part of our ongoing commitment to supporting healthcare providers and people living with diabetes, we’re excited to share the latest enhancements and features now available in Glooko Web 25.1 and Mobile 6.11. These updates are designed to streamline workflows, improve patient engagement and security, and provide care teams with more robust tools to manage diabetes care effectively. Patient Notes and Medications in Week View Care teams and people living with diabetes can now view notes and medication entries added to the Glooko Mobile and Web App directly in Week View, both online and in PDF reports. These entries appear in a new collapsible “Events” section below each day, making it easier to contextualize trends in glucose data and treatment behaviors. Streamlined Week View PDF Reports In our new release, Week View PDFs are now cleaner and more efficient. Sections without data will be automatically hidden, allowing more patient data over a few days to fit on each page. The glucose and statistics sections will always remain, and a single, comprehensive legend will now appear at the end of the report. Smarter Defaults in the PDF Wizard for Hybrid Closed Loop Systems Designed to streamline reporting workflows and help care teams quickly access the most meaningful insights, the Glooko PDF Wizard now automatically pre-selects the most relevant reports, including Summary, Week, Daily, and Devices, when a patient uses a Hybrid Closed Loop System like Omnipod® 5, Tandem t:slim X2 with Control-IQ technology, or mylife Loop powered by CamAPS® FX. Care teams can still customize the selections as needed. Enhanced Security in the Glooko Mobile App At Glooko, we’re committed to the security and safety of our platform users. People living with diabetes, including those under age 18, can now manage their login credentials (email and password) through a new Login Security section in the Glooko Mobile App’s Account Settings. We’ve also expanded support for two-factor authentication (2FA) to users to ensure an extra layer of protection. Explore More Updates For more detailed information about the new features designed to simplify diabetes management, be sure to check out the full release notes on the Glooko Support Center.
Learn more
From Clinic to Innovation: Guiding Glooko’s Future in Diabetes Management
June 3, 2025As healthcare providers, we find ourselves at a pivotal moment in diabetes management. Technological advances — from remote patient monitoring to artificial intelligence — have dramatically reshaped patient care. Yet, amid these innovations, a crucial element often remains overlooked: the voices of clinicians and people with diabetes. In my new expanded role as Chief Medical and Strategy Officer at Glooko, I am excited about the opportunity to transition from direct patient care into a broader role where I can continue to make a significant impact on diabetes management and improve the lives of people with diabetes. I believe my firsthand clinical experience positions me uniquely to guide Glooko’s innovation efforts, ensuring we build tools that genuinely meet the needs of clinicians and people with diabetes alike. In my nearly two decades as a pediatric endocrinologist, I’ve observed the profound potential—and the challenges—of integrating digital solutions into daily diabetes management. Clinicians routinely manage a complex array of tasks: reviewing glucose data from continuous glucose monitors (CGMs) or meters, adjusting insulin regimens, coaching patients on lifestyle, documenting clinical decisions, and coordinating across care teams. With a single person’s CGM device generating up to 288 data points per day, 1 clinicians managing numerous people with diabetes face overwhelming workloads. Individuals with diabetes echo similar concerns. Many describe data fatigue from constant management and analysis of their glucose levels. As one person stated, “The data is overwhelming; without clear insights and simpler ways to interpret it, it’s just noise.” Although this wealth of data is invaluable, it contributes significantly to clinician burnout, and burn out among people with diabetes. Alarmingly, half to two-thirds of clinicians experience burnout, driven largely by bureaucratic tasks, extended working hours, and the sheer volume of data management.2,3 Individuals with diabetes also report significant stress from managing their condition daily. Every glucose reading can feel like a pass or fail test. Effective technological integration could alleviate such emotional burdens by making data actionable, intuitive, and less intrusive. At Glooko, we recognize that technology alone is not sufficient—it must seamlessly integrate into clinician workflows. Clinicians offer essential insights into behaviors of individuals, adherence barriers, and preferences. Unfortunately, many digital diabetes solutions miss the mark due to inadequate clinician input, leading to underutilization—only about 40% see active clinical use.4 Glooko addresses this by ensuring clinician insights directly shape our technology, streamlining workflow integration through interoperability with electronic health records (EHRs). In a similar vein, simplicity and intuitive user experiences are paramount for people with diabetes to properly leverage diabetes management technologies. If the technology is complicated, it just becomes another barrier. Today, our connected care platform exemplifies this integrated approach, merging patient-generated data with clinical decision-making tools. Evidence demonstrates connected care significantly improves diabetes outcomes, with reductions in HbA1c levels of up to 1.5% and fewer hypoglycemic events.5 Glooko enables clinicians to swiftly identify high-risk trends and proactively manage care for people with diabetes. Tomorrow, AI-driven predictive analytics within Glooko could transform diabetes management by forecasting hypoglycemic and hyperglycemic events, facilitating timely, preventive interventions. Automating routine data analysis tasks can reduce clinicians’ documentation burdens by approximately 30%,6,7 significantly alleviating stress and freeing clinicians to focus more deeply on clinical interactions. For people with diabetes, this can provide a significant improvement in their overall diabetes management. I believe Glooko has immense potential, especially through advanced analytics and decision support. For instance, we could empower clinicians to shift from generalized treatment plans to highly personalized management strategies, grounded in timely data. Innovation that is guided by those on the frontlines of care — people with diabetes and their care providers — is critical for meaningful advancements that can truly move the needle in diabetes care. In my role, I am dedicated to ensuring our solutions enhance workflows, support better outcomes, and ultimately bring a human-centric approach to diabetes management. Together, we will define the future of diabetes care, directly addressing challenges clinicians face and improving the lives of those we treat. Here’s to a bright future ahead! 1. Speakman, ASHP. 2. Hammes et al., Endocrine News; Medscape Endocrinologist Lifestyle Report, 2022. 3. Batta et al., BMJ Open Diabetes Res Care. 4. Shah et al., J. Diabetes Sci Technol., 2023.5. Su et al., J. Med Internet Res., 2023. 6. AMA Digital Health Report. 7. Sidharthan et al., Scientific Reports, 2025.
Learn more
Helping Combat Clinician Burnout through EHR Integrations
May 22, 2025At Glooko, we empower healthcare providers with the tools and insights they need to make informed decisions quickly and easily to improve the health outcomes of their patients living with diabetes. With nearly half of physicians reporting at least one burnout symptom in a recent study from the American Medical Association, it’s critical we make diabetes data management simpler to not overburden those providing care. That’s why the Glooko platform integrates with leading electronic health record (EHR) systems in the U.S., including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and AthenaHealth, making our diabetes management platform seamlessly and securely available within this critical healthcare technology and eliminating the need to platform switch. Why EHR Integrations Matter Diabetes care is complex, and healthcare providers face the challenge of managing patient data across multiple systems. In an era where time is precious and clinicians are already spending much of their time on administrative tasks, clinicians need timely access to the most relevant health data without the inefficiencies of navigating multiple data platforms. By integrating Glooko into EHRs, we streamline how healthcare providers access diabetes data, enabling them to provide the highest quality care. Our integrations provide clinicians and care teams with immediate access to comprehensive data from more than 200 diabetes and health monitoring devices used by their patients, eliminating the need for additional logins and manual data entry by people living with diabetes each day. EHR integrations not only optimize existing systems, but they also have the potential to enhance clinical decision-making by giving clinicians the full picture of a person’s health. It empowers them to make faster, more informed treatment decisions. That’s why health systems spend $2.5 million to $1.2 billion on EHR integrations each year. They’re powerful and their care teams can reap the benefits of reduced documentation burden. How It Works By leveraging SMART on FHIR technology and HL7, standard interoperability frameworks, Glooko integrates with existing EHR systems at hospitals and health systems. Healthcare providers can then access patients’ timely glucose data, medication logs, activity levels, food intake, and much more without leaving the EHR. The integrations support healthcare systems by offering a single, unified view of a person’s diabetes information, all while ensuring secure, HIPAA-compliant data exchange. The technology is designed to streamline workflows, making it easier for clinicians to focus on what truly matters: providing quality care for their patients. A Step Toward the Future of Diabetes Care Following the COVID-19 pandemic, clinical teams who provide care to the more than 38 million people in the U.S. living with diabetes have greatly declined in number, furthering the urgent need for seamless, data-driven solutions to help reduce administrative burdens and workloads that drive burnout. Since 2022, more than 138,000 nurses left the workforce due to stress, burnout, and retirement. New data from the NCSBN reveals almost 40% of nurses intend to leave the workforce by 2029, leaving the remaining time-pressed nurses to provide care to an already large patient population. Based on a recent GoodRx study, more than 70% of U.S. counties don’t have an endocrinologist and the number of trained endocrinologists is declining, meaning primary care providers must be knowledgeable in diabetes management and shoulder the workload. There is a significant shortfall of certified diabetes care and education specialists (CDCES), impacting diabetes care quality. In the U.S., there are about 19,500 diabetes educators — roughly 1 CDCES per 1,000 individuals with diabetes. An additional 35,000 educators would be required to meet the current demands of patients in the U.S. alone, furthering the workload burden. And the burnout by clinicians and care teams is only going to grow greater as 98 million American adults have prediabetes, according to the CDC. By optimizing and integrating with leading EHR systems, Glooko is taking a significant step forward in transforming diabetes management and reducing extra steps taken by healthcare providers to improve the quality of care. Our integrations help improve workflows, limit platform switching, simplify clinical decision-making, and support better outcomes for both healthcare providers and people with diabetes. These integrations represent our ongoing commitment to delivering cutting-edge, interoperable solutions that empower both clinical teams and patients in making diabetes easier to manage. Ready to Learn More? Healthcare providers and hospital systems can access EHR integrations by reaching out to our dedicated team for a demo. With robust support from our dedicated team, some integrations, like with Epic, can be up and running within a weeks, making it easier than ever to take advantage of the benefits Glooko has to offer. To learn more about Glooko’s many EHR integrations, visit our Integration Portal.
Learn more
The Power of Food Logging: A Smarter Way to Manage Diabetes with Glooko
May 15, 2025Food and nutrition play a vital role in achieving a healthy lifestyle. This is particularly important in diabetes management, especially for people living with Type 2 diabetes. In the Glooko Mobile App available on the App Store and Google Play Store, people living with diabetes can easily log what they eat at home or while on the go using our food tracking feature, a popular functionality that always receives praise from our users. Through our integration with the world’s largest dietitian-verified grocery database of more than 1 million items from over 46,000 grocery brands, users of the Glooko Mobile App can accurately track their meals and snacks in a variety of ways and create a personal log to better understand how food and nutrition impacts their diabetes. Glooko offers many options for logging food intake: Search the largest grocery database on the planet: Easily find and add generic or branded foods by typing the name into the app. Learn how to use this feature… Use the innovative voice capture capability: Simply speak the name of a food item to log it in Glooko. Find out how to use the voice capture feature… Scan barcodes: Use a smartphone camera to scan packaged food barcodes to instantly access nutritional information and effortlessly add to the app’s log. See how to use the barcode scanner functionality… By viewing food and nutrition data, including carbohydrates, calories, fats, and proteins, alongside insights from their connected diabetes and health monitoring devices, medications, and insulin, users can uncover trends and make smarter food choices. Since people don’t need to log into multiple platforms to manage both their diabetes and nutrition data, we’ve recently seen an increase in food logging frequency and more tracking of localized food items around the world. More ways to eat smart and track more effectively using the Glooko Mobile App To better serve the diverse needs of users around the globe, Glooko has localized food items searchable in German, French, Spanish, Italian, UK English, and US English to support people living with diabetes in these regions. Frequent users can also save time by creating custom food entries for their favorite meals — perfect for quick re-logging of their go-to foods. To better serve the diverse needs of users around the globe, Glooko has localized food items searchable in German, French, Spanish, Italian, UK English, and US English to support people living with diabetes in these regions. Glooko Mobile App users can complement their food logging with quick notes using free text or the dropdown menu option to provide details like miscalculated carbs, overeating, dining out, or skipped meals. These notes help communicate important context to their healthcare team who can provide more information dietary or medication recommendations as needed. Share nutrition data with healthcare providers While we’ve really focused on the benefits of food tracking for people living with diabetes, healthcare providers and care teams also benefit from this feature. They can view this logged nutrition data alongside their patients’ other health data in Glooko to have a more comprehensive view of everything affecting their patients’ diabetes. The evolution of our food tracker Glooko plans on further innovating its app to provide advanced food analysis tools, including micronutrients, more photos, and easier logging, and personalized nutrition insights with real-time feedback on how specific food choices directly impact a person’s health. An advanced, data-driven approach will empower people living with diabetes to make even timely, smarter, and more informed decisions about their health. Download the Glooko Mobile App today Ready to take diabetes management to the next level? Download the Glooko Mobile App from the App Store or Google Play Store and start logging food, tracking health data, and uncovering insights that support better living with diabetes.* *Not all product features are available in all countries. *Not all product features are available in all countries.
Learn more
How Glooko is Transforming Diabetes Care: My First Six Months as CEO
April 4, 2025Over the past several months since stepping into the role of CEO at Glooko, I’ve been reflecting on the incredible progress we’ve made, and the immense opportunities that lie ahead. Each day has reaffirmed my belief that our mission to transform diabetes care is both urgent and achievable. I’m more energized than ever to guide Glooko toward a future where we deliver an even greater impact for people with diabetes and those who care for them. When I think about the future of diabetes care, one word comes to mind: transformation. Across the globe, health systems, clinicians, and people living with diabetes are looking for a holistic approach, one that brings together cutting-edge technology, patient-centric insights, and secure, scalable solutions. At Glooko, we’ve made it our mission to deliver exactly that. Our Vision: Transforming Diabetes Care We believe in transforming diabetes care by making it simpler, more connected, and fundamentally centered on people with diabetes. This vision underpins every decision we make, whether we’re enhancing our platform’s EHR integration, partnering with global device manufacturers, or expanding our footprint in new markets. Our Mission: Simplifying Care and Strengthening Connections At Glooko, we say: “We simplify care, strengthen connections, and together create a brighter future for people living with diabetes, healthcare providers, and caregivers.” Simplify Care We hear time and again about fragmented workflows and siloed data, forcing providers and patients to juggle multiple device platforms (mobile and web), apps, and logins. Our platform intends to change this, meaning clinicians can potentially spend less time on administrative tasks and more time where they’re needed most: caring for patients and focused on improving outcomes. Strengthen Connections We also see the power of community and shared decision-making. Through Glooko, patients, caregivers, and healthcare teams can collaborate more effectively, share real-time data, and gain insights that drive meaningful change in care plans. We aim to reduce the cognitive burden of diabetes data and decision making. In my view, these are the five biggest differentiators that make Glooko stand out: Patient First Mindset: Everything we do revolves around putting patients first. We collaborate closely with clinicians, caregivers, and people living with diabetes to ensure our technology meets real-world needs. Commitment to Quality and Security: From ISO 27001 to HiTrust and SOC 2 Type 2 certifications, our platform is backed by enterprise-grade security and rigorously tested reliability. We understand that healthcare data is precious and that trust is earned through quality. Innovation That Matters: Our platform is more than a “data upload tool.” It’s an engine designed to support clinical decision making. Whether it’s EHR interoperability or automated patient nudges, we constantly push boundaries to develop meaningful solutions that scale globally. High-Performance Culture: Within the company, we’re building a talented, global team that challenges the status quo. This energy fuels our drive to expand into new markets, partner with industry leaders, and improve access to diabetes care around the world. Better Together: Collaboration is in our DNA, and that includes partnerships with device manufacturers, healthcare providers and hospital systems. By joining forces with stakeholders across the healthcare ecosystem, we have the opportunity to create value that benefits everyone, especially people living with diabetes. Scaling for the Future Our work has already touched millions of lives, but we’re just getting started. With rising rates of diabetes worldwide, the need for an integrated, secure, and human-centered solution has never been greater. That’s why we’re investing in global expansion, forging new alliances, and refining our platform to make sense of the high volume of data in diabetes care. Scaling effectively also means staying true to our roots. Our commitment to patient outcomes, uncompromising quality, and secure innovation will remain the bedrock of Glooko’s growth. As we continue to expand, our North Star will always be the same: transforming diabetes care on a global scale and making diabetes easier to manage for everyone in the diabetes care ecosystem. A Commitment to People Living with Diabetes, Above All Behind every data point or device upload is a person managing a complex, life-altering condition. We never lose sight of that human element. As Glooko grows, our Patients First value continues to guide us toward solutions that truly make a difference, reducing clinical burdens, improving outcomes, and helping people with diabetes live fuller, healthier lives. MKT-0532 01
Learn more
Empowering Diabetes Management: A Vision for the Future
November 14, 2024November is Diabetes Awareness Month, a time to reflect on the impact of diabetes on millions of people worldwide and to raise awareness about how we can improve care, outcomes, and quality of life for those living with the condition. At Glooko, we are deeply committed to this mission. Every day, our team works tirelessly to create innovative tools and solutions that empower people with diabetes and their healthcare providers to make informed, life-changing decisions. We spoke with key members of our team who are at the forefront of developing these transformative solutions. Their passion, expertise, and personal commitment to improving diabetes care shine through in their work, and we’re excited to share their perspectives on how we’re shaping the future of diabetes management. Matteo Carli, Senior Director of Product at Glooko, shares our core mission: “Our goal is to bridge the gap between data and actionable care, simplifying diabetes management and enabling more personalized, proactive care.” A key area of passion for Matteo is our Population Health tools, which help healthcare teams proactively identify high-risk patients and deliver preventive care at scale, improving outcomes across communities. “What motivates me most is the belief that every improvement we make to the Glooko platform brings us closer to empowering people with diabetes and their care teams to achieve healthier, more fulfilling lives,” Matteo adds. “With each step forward, we’re not just refining a tool—we’re shaping a future where diabetes care is more connected, personalized, and transformative for everyone involved.” For Amanda Martin, Director of Product Design and a person with Type 1 Diabetes, the mission is personal: “I have the privilege of creating solutions that empower people with diabetes and the providers who care for them. As a person with Type 1 Diabetes, I love being part of a team dedicated to making meaningful experiences for patients to improve their care and transform their lives.” Amanda’s unique perspective drives her commitment to designing tools that improve daily diabetes management. “I love how our team brings together passion, empathy, and innovation to create experiences that truly make a difference for those with diabetes.” This Diabetes Awareness Month, we renew our commitment to reshaping the future of diabetes care—empowering patients, supporting providers, and improving lives. MKT-0504 01
Learn more
Making Diabetes Management Easier for All:
Glooko’s Renewed Vision for the Future
October 22, 2024
As I begin my new role as CEO of Glooko, I’m filled with both excitement and a deep sense of responsibility. Diabetes management has always been a deeply personal and complex journey for so many individuals, and the opportunity to lead a company dedicated to easing that burden is truly inspiring. This is more than just a new chapter for me; it’s a chance to make a real difference in the lives of people living with chronic conditions. With the $100 million Series F financing, Glooko is in a strong position to accelerate our mission—simplifying diabetes management for patients, clinicians, and their care teams. As someone who has spent the majority of my career in healthcare technology and chronic condition management, I’m particularly excited to lead a company that is committed to easing the burden for patients with diabetes and their care teams. I’ve seen firsthand how data—while crucial—can become overwhelming, especially for those managing a condition like diabetes that requires constant monitoring. Whether it’s managing blood glucose levels, using insulin pumps, or trying to make sense of data from multiple apps, patients and clinicians are often left navigating a complex web of information. Particularly for physicians, sifting through and trying to make sense of that same sea of data to provide timely, effective care can be a daunting task. At Glooko, we’re focused on tackling these challenges head-on. Our platform has the potential to provide actionable insights that streamline the management of chronic diseases like diabetes. We aim to simplify workflows, so that endocrinologists and diabetes care teams can focus on what matters most—to develop early intervention and care pathways that improve patient outcomes. We are also focused on expanding our work with our life sciences partners to enable clinical research and improve outcomes. Our goal is clear: to make diabetes management easier for everyone—patients, clinicians, and partners. With the recent funding, we’re able to invest further in expanding our platform to support even more customers and to strengthen our integrations with electronic medical records (EMRs). This not only helps clinicians manage their workloads more effectively but also improves care coordination across the board. I couldn’t be more excited to lead Glooko through this next phase of growth. We are at the forefront of changing how chronic diseases are managed by leveraging data to create new care pathways that make a real difference in patients’ lives. The possibilities for what we can achieve together are limitless, and I’m eager to work with our incredible team to bring these innovations to life. This moment marks the beginning of an exciting journey, and I’m confident that, together, we’ll continue to set new standards for chronic condition management—making it easier, more efficient, and more effective for all.
Learn more
Blood Sugar-Friendly Leftover Hacks from Glooko’s Resident Registered Dietitian
November 20, 2023Get blood sugar-friendly leftover hacks from Glooko’s resident registered dietitian, Bridget Wood, RD, LD, CDCES
Learn more
Design a New Resistance Exercise Program With Glooko’s Resident Fitness Expert!
October 30, 2023Glooko's Sanaz Nosrat, PhD, CSCS, ACE PT outlines the benefits of resistance exercise and will give you some tips on how to design and stick to your program.
Learn more
Tips for Better Diabetes Management When Travelling
August 17, 2023Glooko’s Amanda Stoney, RN (CHILD), BSc (HONS), Specialist Practitioner, PG Certificate shares tips for better diabetes management when travelling.
Learn more
An Educational Summer Internship Experience at Glooko
August 16, 2023This summer, Glooko has interns in various functions of our global digital health company who are helping us improve our connected care technologies.
Learn more
Keep Cool This Summer with Healthy Eating Tips from Glooko’s Resident Registered Dietitian
July 28, 2023Glooko's Bridget Wood, RD, LD, CDCES shares healthy recipes and tips to help people with diabetes and related chronic conditions stay cool this summer.
Learn more
Top 3 Things You Don’t Want to Miss from Glooko at ADCES23
July 21, 2023Glooko will share the latest features of its connected care platforms for diabetes at Association of Diabetes Care & Education Specialists’ ADCES23.
Learn more
Glooko Showcases its Connected Care Solutions that Improve Health Outcomes at the American Diabetes Association (ADA) 83rd Scientific Sessions
July 12, 2023Glooko showcased how its innovative connected care platforms improve health outcomes at the American Diabetes Association (ADA) 83rd Scientific Sessions.
Learn more
Discussing All Things Diabetes with Glooko’s Bridget Wood, RD, LD, CDCES and her Diabesties
June 30, 2023Glooko's Bridget Wood, RD, LD, CDCES discusses all things diabetes and management of the chronic condition with her diabesties.
Learn more
Design A New Aerobic Exercise Program with Glooko’s Resident Fitness Expert
June 14, 2023Glooko's Sanaz Nosrat, PhD, CSCS, ACE PT outlines the benefits of aerobic exercise and how to design a workout program for people living with diabetes and related chronic conditions.
Learn more
Satisfying Salad Creations with Glooko’s Resident Registered Dietitian
May 26, 2023For National Salad Month, Glooko's Bridget Wood, RD, LD, CDCES shares how to create a satisfying salad for people with diabetes and related chronic conditions.
Learn more